Status:
COMPLETED
Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
To study the properties of different tablets/capsules of AZD1305 in healthy male volunteers.
Eligibility Criteria
Inclusion
- Healthy male between the age of 20 - 45
- Non-smoking
Exclusion
- Potassium outside normal reference values
- ECG findings outside normal range
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00689403
Start Date
February 1 2008
End Date
July 1 2008
Last Update
December 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Harrow, United Kingdom